SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Immunic, Inc. – ‘10-K’ for 12/31/23

On:  Thursday, 2/22/24, at 6:38am ET   ·   For:  12/31/23   ·   Accession #:  1280776-24-4   ·   File #:  1-36201

Previous ‘10-K’:  ‘10-K’ on 2/23/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   11 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/22/24  Immunic, Inc.                     10-K       12/31/23   76:15M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.38M 
 2: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     33K 
 3: EX-19       Report Furnished to Security Holders                HTML    110K 
 4: EX-21.1     Subsidiaries List                                   HTML     22K 
 5: EX-23.1     Consent of Expert or Counsel                        HTML     22K 
10: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     61K 
                Awarded Compensation                                             
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
16: R1          Cover Page                                          HTML     89K 
17: R2          Audit Information                                   HTML     27K 
18: R3          Consolidated Balance Sheets                         HTML    119K 
19: R4          Consolidated Balance Sheets (Parenthetical)         HTML     42K 
20: R5          Consolidated Statements of Operations               HTML     73K 
21: R6          Consolidated Statements of Comprehensive Loss       HTML     42K 
22: R7          Consolidated Statements of Stockholders' Equity     HTML     84K 
23: R8          Consolidated Statements of Stockholders' Equity     HTML     26K 
                (Parenthetical)                                                  
24: R9          Consolidated Statements of Cash Flows               HTML     97K 
25: R10         Consolidated Statements of Cash Flows               HTML     25K 
                (Parenthetical)                                                  
26: R11         Description of Business and Basis of Financial      HTML     30K 
                Statements                                                       
27: R12         Summary of Significant Accounting Policies          HTML     63K 
28: R13         Balance Sheet Details                               HTML     53K 
29: R14         Commitments and Contingencies                       HTML     39K 
30: R15         Fair Value                                          HTML     44K 
31: R16         Common Stock                                        HTML     52K 
32: R17         Stock-based Compensation Plans                      HTML     75K 
33: R18         Income Taxes                                        HTML     66K 
34: R19         Changes in Board of Directors                       HTML     25K 
35: R20         Related Party Transactions                          HTML     28K 
36: R21         Summary of Significant Accounting Policies          HTML    103K 
                (Policies)                                                       
37: R22         Summary of Significant Accounting Policies          HTML     34K 
                (Tables)                                                         
38: R23         Balance Sheet Details (Tables)                      HTML     56K 
39: R24         Commitments and Contingencies (Tables)              HTML     32K 
40: R25         Fair Value (Tables)                                 HTML     41K 
41: R26         Common Stock (Tables)                               HTML     29K 
42: R27         Stock-based Compensation Plans (Tables)             HTML     68K 
43: R28         Income Taxes (Tables)                               HTML     63K 
44: R29         Description of Business and Basis of Financial      HTML     36K 
                Statements (Details)                                             
45: R30         Summary of Significant Accounting Policies -        HTML     71K 
                Additional Information (Details)                                 
46: R31         Summary of Significant Accounting Policies -        HTML     26K 
                Schedule of Investment (Details)                                 
47: R32         Summary of Significant Accounting Policies -        HTML     30K 
                Schedule of Potentially Dilutive Securities Not                  
                Included in Calculation of Diluted Net Loss per                  
                Share (Details)                                                  
48: R33         Balance Sheet Details - Schedule of Prepaid         HTML     34K 
                Expenses and Other Current Assets (Details)                      
49: R34         Balance Sheet Details - Schedule of Accounts        HTML     30K 
                Payable (Details)                                                
50: R35         Balance Sheet Details - Schedule of Accrued         HTML     31K 
                Expenses (Details)                                               
51: R36         Balance Sheet Details - Schedule of Other Current   HTML     30K 
                Liabilities (Details)                                            
52: R37         Commitments and Contingencies - Additional          HTML     44K 
                Information (Details)                                            
53: R38         Commitments and Contingencies - Schedule of         HTML     41K 
                Maturities of Operating Lease Obligations                        
                (Details)                                                        
54: R39         Fair Value - Schedule of Financial Assets and       HTML     36K 
                Liabilities Measured at Fair Value on Recurring                  
                Basis (Details)                                                  
55: R40         Fair Value - Additional Information (Detail)        HTML     30K 
56: R41         Common Stock - Shelf Registration Statement         HTML     61K 
                (Details)                                                        
57: R42         Common Stock - Equity Offerings (Details)           HTML     76K 
58: R43         Common Stock - Private Placement Equity Financing   HTML     86K 
                (Details)                                                        
59: R44         Common Stock - Common Stock (Details)               HTML     44K 
60: R45         Common Stock - Preferred Stock (Details)            HTML     29K 
61: R46         Common Stock - Shares Reserved for Future Issuance  HTML     40K 
                (Details)                                                        
62: R47         Stock-based Compensation Plans - Additional         HTML     94K 
                Information (Details)                                            
63: R48         Stock-based Compensation Plans - Schedule of Stock  HTML     74K 
                Option Activity (Details)                                        
64: R49         Stock-based Compensation Plans - Schedule of        HTML     42K 
                Valuation Assumptions Used (Details)                             
65: R50         Stock-based Compensation Plans - Schedule of        HTML     31K 
                Stock-based Compensation Expense for Stock Awards                
                Recognized (Details)                                             
66: R51         Income Taxes - Schedule of Net Loss Before Income   HTML     33K 
                Tax Based on Jurisdictions (Details)                             
67: R52         Income Taxes - Schedule of Income Tax Rate          HTML     42K 
                Reconciliation (Details)                                         
68: R53         Income Taxes - Additional Information (Details)     HTML     44K 
69: R54         Income Taxes - Schedule of Deferred Tax Assets and  HTML     48K 
                Liabilities (Details)                                            
70: R55         Changes in Board of Directors (Details)             HTML     25K 
71: R56         Related Party Transactions - Additional             HTML     30K 
                Information (Details)                                            
73: XML         IDEA XML File -- Filing Summary                      XML    125K 
76: XML         XBRL Instance -- imux-20231231_htm                   XML   1.01M 
72: EXCEL       IDEA Workbook of Financial Report Info              XLSX    128K 
12: EX-101.CAL  XBRL Calculations -- imux-20231231_cal               XML    153K 
13: EX-101.DEF  XBRL Definitions -- imux-20231231_def                XML    574K 
14: EX-101.LAB  XBRL Labels -- imux-20231231_lab                     XML   1.34M 
15: EX-101.PRE  XBRL Presentations -- imux-20231231_pre              XML    861K 
11: EX-101.SCH  XBRL Schema -- imux-20231231                         XSD    138K 
74: JSON        XBRL Instance as JSON Data -- MetaLinks              392±   583K 
75: ZIP         XBRL Zipped Folder -- 0001280776-24-000004-xbrl      Zip    631K 




        
Filing Submission 0001280776-24-000004 – SGML Text

Original SGML Text submitted by:  Immunic, Inc.

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 10:09:13.2am ET